Fact CheckerSign in

NCT05501964Completed

Predictors and Outcomes of Time to Hemostasis After Cardiac Catheterization

Predictors and Outcomes of Time to Hemostasis Post Trans-femoral Cardiac Catheterization: a Multicenter Cohort Study

Source: ClinicalTrials.gov · Last updated 26 Jun 2024

Brief summary (registry, in English)

This study aims to: 1. Assess the incidence of hemostasis failure after manual compression of trans-femoral arterial sheath post percutaneous coronary intervention. 2. Assess the predictors of time to hemostasis achieved by manual compression for trans-femoral arterial sheath post percutaneous coronary intervention. 3. Assess the association between time to hemostasis and the incidence of vascular access complications after manual compression for trans-femoral arterial sheath removal post percutaneous coronary intervention. 4. Assess the association between failed hemostasis and the incidence of vascular access complications after manual compression for trans-femoral arterial sheath removal post percutaneous coronary intervention.

Status (registry)
Completed
Study type
Observational
Enrollment
300 (actual)
First submitted
6 Aug 2022
Start date
Aug 2022
Primary completion date
May 2024
Lead sponsor
Alexandria University
NCT number
NCT05501964

What you commit to

  • Study type: Observational
  • Participants enrolled: 300
  • From Aug 2022 to the primary completion date, May 2024
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • patients with a known history of coagulation disorders,

Lab values

  • patients with sheath removed at the laboratory, and

Other

  • Patients who had trans-femoral catheterization procedure within a 1-month duration
  • Patients who experience post - catheterization life-threatening events rather than vascular access complications

Who the study is looking for

  • Patients who planned for elective or primary percutaneous coronary intervention with femoral access, and
  • Agreed to participate in the study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mabaret Aalsafra hospital
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status
Smouha University hospital
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status
Shark El-Madina Hospital
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status
Andalusia Private Hospital
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status
German Heart Center
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.